Guide for Developing HIV and Opioid Use Disorder Service Inventories and Using Geographic Mapping
Resource updated 01/05/2024
Resource updated 01/05/2024
Resource updated 09/19/2023
Resource updated 09/19/2023
Blog updated 03/28/2024
Resource updated 04/03/2024
Resource updated 03/23/2023
RWHAP Technical Assistance Provider updated on 02/27/2024
Resource updated 09/19/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 01/05/2024
Creation on pop-up mobile clinics, created in partnership with an established Syringe Support Program (SSP) and academic organizations, to provide one stop STI/HCV/HIV testing and COVID-19 vaccination for people experiencing substance use/homelessness, who have increased risks for these conditions.
Resource (Conference Presentation) updated 09/14/2023
Description of HRSA's Best Practices Compilation (targethiv.org/bestpractices), which allows organizations to submit information about their interventions and to search and identify interventions that may work for them.
Resource (Conference Presentation) updated 09/14/2023
Following Hurricane Ida in New Orleans, Tulane ID providers utilized an innovative communication model to contact patients using a Google Voice number to act as the clinic call back number. Using this model, 88 out of 132 patients were successfully reached, with 36 percent of those that answered requiring urgent refills.
Resource (Conference Presentation) updated 09/14/2023
The U.S. opioid epidemic has significant impact on rates of overdose deaths among people with HIV. The aim of the project was to leverage the PDSA methodology to enhance a population-based, health information technology, intervention to facilitate the identification and panel management of high-risk clients with opioid use disorder.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 03/13/2024
Guide to help ADAPs prepare for and manage emergencies in order to ensure continued access to HIV medications.
Resource updated 09/19/2023